Provided by Tiger Trade Technology Pte. Ltd.

HilleVax, Inc.

2.09
0.0000
Volume:- -
Turnover:5.86M
Market Cap:104.79M
PE:-1.46
High:2.09
Open:2.09
Low:2.09
Close:2.09
52wk High:2.17
52wk Low:1.34
Shares:50.14M
Float Shares:28.05M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4286
EPS(LYR):-2.9961
ROE:-40.31%
ROA:-14.48%
PB:0.71
PE(LYR):-0.70

Loading ...

Company Profile

Company Name:
HilleVax, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.